Vanda Pharmaceuticals is a biopharmaceutical company that develops and commercialises medicines for disorders of the central nervous system and sleep. Its products include treatments for non-organic sleep-wake cycle disturbance and for schizophrenia, prescribed by specialist physicians and sold in the United States and other markets. The company is based in Washington, District of Columbia, and carries out clinical development alongside its commercial activities.
Vanda Pharmaceuticals Inc. trades under the code 0LKB on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3682 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
7/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-37.1%
From 52-week high-58.7%
MomentumWeak
8/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-25.9%
6-month return-40.6%
Stability (higher is calmer)Weak
13/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)73.6%
Worst drawdown, 1 year (smaller is calmer)-58.7%
LiquidityWeak
20/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.03M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 3.890 – 10.240Daily closes, split-adjusted
Signals
50-day average4.921
200-day average6.281
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.202
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 11 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
4.17
Bearish
EMA 10
4.18
Bearish
SMA 20
4.45
Bearish
EMA 20
4.40
Bearish
SMA 50
4.92
Bearish
EMA 50
4.81
Bearish
SMA 100
5.30
Bearish
EMA 100
5.25
Bearish
SMA 200
6.28
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
27.53
Bullish
MACD (12, 26)
-0.27
Bearish
Momentum (12)
-13.69
Bearish
Stochastic %K (14)
7.51
Bullish
Williams %R (14)
-92.49
Bullish
CCI (20)
-108.5
Bullish
Pivot points (classic, last session)
S3
3.54
S2
3.72
S1
3.83
Pivot
4.01
R1
4.12
R2
4.30
R3
4.41
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
